Skip to main content
. 2022 Sep 23;13:992511. doi: 10.3389/fneur.2022.992511

Figure 2.

Figure 2

Patient inclusion scheme, all patients (n = 122). Total number of patients that were examined as ILBF candidates 01/2019-12/2021. Due to relevant levels of analgosedatives (n = 6), relevant COPD (n = 3). §Due to large cranial osseus defects (n = 8), low cardiac output (vaECMO; n = 5). ILBF+ Test result consistent with irreversible loss of brain function. ILBF- Test result not consistent with irreversible loss of brain function.